retatrutide type 2 diabetes phase 2 results 2024 2025 🚨 Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ Retatrutide UK 2026: Phase 3

JACC 75(17):20992106 Patel KHK, Rohin KR, Arunashis S, Pavidra S, Maddalena A, Fu SN (2022) Obesity as a risk factor for cardiac arrhythmias

2, 13 Dec

Tirzepatide microdosing example Strategy A: Titration with smaller increments (compounded version) Tirzepatide come in the form of prefilled pens in fixed, single-use doses (e.g., 2.5 mg, 5 mg, etc.)

These are generally most pronounced when starting or increasing doses and tend to diminish over time as the body adjusts

Can mixing alcohol and semaglutide cause dangerous blood sugar drops

The broader guide on tirzepatide and autoimmune disease provides additional context